H ispanics are the most rapidly increasing segment of the US population. Demographically, they are characterized by a much younger age structure than the general population although there is considerable heterogeneity among the major Hispanic groups.
1 -2 Mexican-Americans comprise the single largest sector and account for 62% of all Hispanics. The median age of the Mexican-American population is 23.3 years, 1 while that of the general US population is 31.8 years. 3 Despite the relative youthfulness of the Mexican-American population, this group has been shown to bear a disproportionate burden of chronic disease, including elevated prevalences of non-insulin-dependent diabetes mellitus, 4 There does not appear to be a concomitant increase in cardiovascular disease or hypertension. 7 -14 - 16 This is not to suggest that cardiovascular disease has a small impact on the Mexican-American population; indeed, 38% of all deaths in Starr Country, Tex.
(98% Mexican-American) from 1981 to 1986 were attributed to diseases of the heart. 17 This figure is identical to that for the US population during 1982. In many ways this is paradoxical, given that most of the diseases listed previously are known to increase risk for cardiovascular disease. Possibly mediating this paradox is the fact that Mexican-Americans do not appear to have a generally untoward lipoprotein profile. 4 -18 While there are data that relate to the distribution of some lipoproteins among Mexican-Americans, there are virtually no reports on their apolipoprotein profile. In this article, the means and percentile distributions of lipids, lipoproteins, and apolipoproteins (apos) stratified by sex and age are given for a representative sample of Mexican-Americans from south Texas. Measures tabulated include total cholesterol, triglycerides, /3-lipoprotein cholesterol, a-lipoprotein cholesterol, total high density lipoprotein (HDLT) cholesterol and its subtractions (HDL2 and HDL3), low density lipoprotein (LDL) cholesterol, and apos A-I, A-II, B, C-II, C-III, and E. The distribution of these factors is particularly important in determining the future impact of chronic disease in Mexican-Americans because the burden will only increase as the population ages.
Methods
The Mexican-American population of Starr County, Tex., has been described previously.
dwelling unit enumeration to identify a representative sample of the Starr County, Tex., population. Within selected dwelling units, one individual between the ages of 15 and 74 years, inclusively, was randomly selected for a complete physical evaluation that included electrocardiography, physical examination, medical and nutrition histories, ultrasound examination to determine presence of gallbladder disease, and collection of fasting blood samples for the determination of an extensive laboratory profile. Sampling continued until a target of 1,000 individuals was obtained (final sample size was 1,004). All protocols were reviewed and approved by the Institutional Committee for the Protection of Human Subjects, and informed consent was obtained from each individual.
Examinations were performed on weekends on an approximately monthly basis from April 1985 to November 1986. Fasting blood samples were centrifuged within 2 hours of collection, and the plasma was separated and stored at 4°C for later analysis. Cholesterol, triglycerides, HDLT, and HDL3 were determined with standard protocols and dextran sulfate/Mg 2+ precipitation. 19 HDL2 was calculated by subtraction. Heparin-affinity chromatography columns 20 (LDL-Direct, Isolab, Akron, Ohio) were employed to measure a-and ^-lipoprotein fractions. Levels of LDL were calculated by subtraction of HDLT and very low density lipoprotein (VLDL) cholesterol from total cholesterol. Triglyceride values divided by five were used as an estimate of VLDL. 21 All these determinations were made within 5 days of sample collection.
Funding for this project came from two nonconcurrent sources and consequently, levels of the apos were not determined on samples collected in the first year. Apo levels were measured on all samples from April 1986 to the end of sampling. An effort was also made to recollect fasting blood samples from women aged 35-55 years who had been seen before April 1986. This generated 100 samples to augment the regular collections. Except for apo A-I, which was determined from frozen samples, all apo determinations were made within 5 days of sample collection. Apo A-I was determined by radioimmunoassay (Ventrex, Portland, Me.). Apo B levels were measured by rocket immunoelectrophoresis 22 (antisera from Boehringer Mannheim, Mannheim, F.R.G.). Radial immmunodiffusion 23 (Daiichi Pure Chemical, Tokyo, Japan) was used to measure concentrations of apos A-II, C-II, C-III, and E. All apos were analyzed in duplicate with additional reruns as necessary. Values reported here represent the mean±SEM of duplicate measures.
To control assay quality, a number of additional procedures were performed. These included independent lipoprotein analysis of 10% of samples at the Baylor College of Medicine Atherosclerosis Clinical Laboratory where the same (although more automated) procedures are used and which is involved in the International Union of Immunological SocietiesNational Heart, Lung, and Blood Institute-Centers for Disease Control (IUIS-NHLBI-CDC) Collaborative Apolipoprotein Standardization Program for apos A-I and B. There were no significant differences between 82 duplicate cholesterol measures in the two laboratories (paired r=0.1, /?=0.89). The correlation between laboratories for cholesterol was 0.93. Triglycerides were an average of 4.8 mg/dl higher in the reference laboratory (paired /=2.0, /?=0.05) with a between-laboratory correlation of 0.93. HDLT values averaged 1.1 mg/dl higher (paired f=2.2, />=0.03) in the reference laboratory, and the correlation between laboratories was also 0.93. HDL3 and HDLz values averaged 1.4 mg/dl lower (paired t=-1.8, /?=0.08) and 3.1 mg/dl higher (paired f=4.6,/?=0.01), respectively, in the reference laboratory. Correlations between laboratories for these measures were 0.67 and 0.71, respectively. The differences between laboratories are generally small. HDL2 shows the largest difference between laboratories, but this is not surprising since its calculation by subtraction will reflect errors in both HDLT and HDL3, measurements. With regard to the apos, there are no standard reference materials, and it has been demonstrated that there is marked variation in measurements among laboratories. 24 These issues have been partially addressed for apos A-I and B through the IUIS-NHLBI-CDC Collaborative Standardization Program. 24 Through participation in Phase V, we analyzed coded, duplicate samples of IUIS reference material CDC 1883. The mean values obtained by us for apos A-I and B were 90 and 60 mg/dl, respectively. These values should assist in comparing the results presented here with those from other studies. Tables 1 and 2 contain the mean values by sex and age for the lipids and lipoproteins (Table 1) and for the apos ( Table 2 ). The increases in cholesterol, triglycerides, VLDL, LDL, and /3-lipoproteins with age are significant when tested by regression analysis. In each instance, the increase with age is curvilinear, that is, both the linear (age) and quadratic (agesquared) effects were significant. Even though the regressions are significant, the magnitude of the effects are small, with 9% or less of the total variability being explained by variation in age (9% for /3-lipoproteins and 6%, 4%, and 3% for cholesterol, triglycerides, and LDL, respectively). HDLT, HDL,, HDL2, and a-lipoprotein show no significant increases with age. After adjustment for age, the mean levels for all measures in Table 1 (except cholesterol and LDL) between males and females are significantly different.
Results
Because of the reduced number of individuals for whom the apos were determined, it is not possible to provide as detailed an age breakdown for apos in Table 2 as for the lipids and lipoproteins in Table 1 . While not always apparent by simple examination of mean levels by age, there are significant age effects (from regression analysis) for all the apos except apos A-I and E. As noted previously, where age effects were significant, the relation was curvilinear, except for apo C-III (for which the relation was linear) and small (explaining ^6% of the total variation). Ageadjusted mean levels in males compared with females were significantly different for apos B, C-II, and C-III. To provide additional data regarding the distribution of the various measures and to facilitate comparisons with other populations, selected percentile cut points are presented in Tables 3 and 4 . The 90th and 10th percentile values are given for the lipid and lipoprotein measures in Table 3 . The same agedependent relations are seen for the percentile values as for the mean values in Table 1 , indicating a generalized shift in the distribution of values. Because of the paucity of data regarding the distribution of apos in the general population, we have included the median as well as the 90th and 10th percentile points in Table 4 . The median values in Table 4 and the mean values in Table 2 are in quite close agreement, indicating a generally symmetric distribution for the apos. The pattern of change in the 90th and 10th percentile values for the apos is much more variable than either the mean or median value.
Cholesterol, trigrycerides, HDLT, and LDL have been measured in numerous populations and are amenable to population comparisons. In Figures 1-4 , we present the 95th and 5th percentiles for these measures in the Mexican-American population compared with the Lipid Research Clinics (LRC) Program results for the United States and Canada. 25 Cholesterol (Figure 1 ) distributions are quite similar although there is a slight tendency for the 95th percentile to be elevated in both males and females across most age groups. Like cholesterol, the 5th percentiles for trigrycerides (Figure 2 ) in MexicanAmericans are very similar to the LRC data; however, the 95th percentiles for trigrycerides among the Mexican-Americans are uniformly and markedly higher than the corresponding LRC values. HDLT percentiles in Figure 3 are seen to be equivalent for the two populations in males, but Mexican-American No comprehensive studies like the LRC have been done characterizing the distribution of the various apos in the general population. Where comparisons are possible (generally for apos A-I and B only), the mean values in Table 2 tend to be somewhat lower than those in other reports. 26 -28 This is confirmed for young adults through comparisons with the recently published data from the Coronary Artery Risk Development in Young Adults study 29 regarding apos A-I and B. Contributing to these differences may be dissimilarities in analytical techniques. This may be particularly true for apo B determinations, where rocket immunoelectrophoresis has been shown to give lower values compared with other methods. 24 While there may be a tendency toward lower mean values, we note that the pattern of change by age and the relative differences between males and females are in the same direction and of approximately equal magnitude as those in the other reports. Discussion As has been described elsewhere, 9 the MexicanAmerican population of Starr County, Tex., has a high frequency of obesity. Among males and females, 26% and 30%, respectively, would be classified as obese based on an extremely conservative definition of a body mass index greater than 30 (BMI=weight in kilograms=the square of height in meters). Because of the high frequency of obesity, it is not surprising to observe the marked elevation of triglycerides in both sexes and the reduced levels of HDLT in females. 30 -31 Furthermore, the pattern observed is similar to the Upoprotein profile seen among the Pima Indians. 32 Comparing age-and sex-specific mean values between Pima Indians and Mexican-Americans shows that for triglycerides, HDLT, and LDL, the patterns are similar and often overlapping. Except for the youngest males (15-24 years old), mean cholesterol values among the Mexican-Americans are consistently elevated over comparable means for the Pima Indians. Mean cholesterol levels average 18 and 23 mg/dl higher in the Starr County sample for males the role of genetic factors in these diseases. 37 It is also likely that the cardiovascular risk among Mexican-Americans corresponds to the admixture; that is, one would expect risk to be moderated by the presence of Amerindian ancestry. The present results are consistent with this, at least insofar as the lipoproteins are concerned, although cholesterol values among Mexican-Americans are much closer to those of the general US population than to those of the Pima Indians. 
